Department of Nephrology, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Department of Infectious Disease or Clinical Microbiology, University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Eur J Clin Nutr. 2022 Dec;76(12):1748-1754. doi: 10.1038/s41430-022-01181-8. Epub 2022 Jul 29.
BACKGROUND & OBJECTIVE: Chronic kidney disease (CKD) is a common condition in worldwide with underlying causes. The role of trace elements such as copper and zinc in CKD is uncertain. We aimed to examine the relationship of serum copper and zinc with kidney function status and explore its possible effect modifiers in the general population.
Data from 5353 National Health and Nutrition Examination Survey (NHANES) participants from 2011 to 2016 were analyzed for the role of trace elements in the age range 18 to 80 years. The kidney outcomes were reduced estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m and increased urinary albumin-to-creatinine ratio (ACR) ≥ 30 mg/g.
Findings showed a significant positive association between serum copper and urinary ACR (OR = 1.04, 95% CI = 1.00-1.07). Serum copper levels of 18.0 μmol/L (median) or higher (reference level <18.0 μmol/L) were significantly associated with increased urinary ACR (OR = 1.67, 95% CI = 1.21-2.31) after adjusting for confounding factors. In contrast, there was a significant inverse association between serum zinc and reduced eGFR (OR = 0.89,95% CI = 0.81-0.99). Where serum zinc level was greater than 12.3 μmol/L (median), the prevalence of reduced eGFR was lower (OR = 0.65, 95% CI = 0.16-0.60). In addition, a stratified analysis based on various risk factors found that in those individuals with serum albumin greater than 43 g/L or systolic blood pressure greater than 120 mmHg, positive correlations between serum copper and risk of increased urinary ACR was more significant.
Our findings suggest that the reference levels of serum copper and zinc levels in healthy individuals may be different from current understanding. If further studies substantiate the same, the results will be a useful guide for designing future clinical trials and nutritional guidelines.
慢性肾脏病(CKD)是一种常见的全球性疾病,其潜在病因多种多样。微量元素如铜和锌在 CKD 中的作用尚不确定。本研究旨在探讨血清铜和锌与肾功能状态的关系,并探索其在一般人群中的可能效应修饰因子。
分析了 2011 年至 2016 年期间来自 5353 名国家健康与营养调查(NHANES)参与者的数据,以研究微量元素在 18 至 80 岁年龄范围内的作用。肾脏结局为估算肾小球滤过率(eGFR)<60ml/min/1.73m 降低和尿白蛋白/肌酐比值(ACR)≥30mg/g 增加。
研究结果显示,血清铜与尿 ACR 呈显著正相关(OR=1.04,95%CI=1.00-1.07)。血清铜水平为 18.0μmol/L(中位数)或更高(参考水平<18.0μmol/L)与调整混杂因素后尿 ACR 增加显著相关(OR=1.67,95%CI=1.21-2.31)。相比之下,血清锌与 eGFR 降低呈显著负相关(OR=0.89,95%CI=0.81-0.99)。当血清锌水平大于 12.3μmol/L(中位数)时,eGFR 降低的患病率较低(OR=0.65,95%CI=0.16-0.60)。此外,基于各种危险因素的分层分析发现,在血清白蛋白大于 43g/L 或收缩压大于 120mmHg 的个体中,血清铜与尿 ACR 风险增加之间的正相关更为显著。
本研究结果表明,健康个体的血清铜和锌参考水平可能与目前的认识不同。如果进一步的研究证实了这一点,结果将为未来的临床试验和营养指南设计提供有用的指导。